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ABSTRACT
The potent anticancer drug actinomycin D (ActD)
functions by intercalating into DNA at GpC sites,
thereby interrupting essential biological processes
including replication and transcription. Certain
neurological diseases are correlated with the ex-
pansion of (CGG)n trinucleotide sequences, which
contain many contiguous GpC sites separated by a
single G:G mispair. To characterize the binding of
ActD to CGG triplet repeat sequences, the structural
basis for the strong binding of ActD to neighbouring
GpC sites flanking a G:G mismatch has been
determined based on the crystal structure of ActD
bound to ATGCGGCAT, which contains a CGG
triplet sequence. The binding of ActD molecules to
GCGGC causes many unexpected conformational
changes including nucleotide flipping out, a sharp
bend and a left-handed twist in the DNA helix via a
two site-binding model. Heat denaturation, circular
dichroism and surface plasmon resonance analyses
showed that adjacent GpC sequences flanking a
G:G mismatch are preferred ActD-binding sites. In
addition, ActD was shown to bind the hairpin con-
formation of (CGG)16 in a pairwise combination and
with greater stability than that of other DNA
intercalators. Our results provide evidence of a
possible biological consequence of ActD binding
to CGG triplet repeat sequences.
INTRODUCTION
Actinomycin D (ActD) (Figure 1) is a potent anticancer
drug. ActD binds to DNA by intercalating its
phenoxazone ring at a GpC step such that the two cyclic
pentapeptides of the drug are located in the DNA minor
groove (1,2). The biological activity of ActD may be
related to its binding to DNA, which interferes with rep-
lication and transcription (3). The GpC sequence speciﬁ-
city of ActD, which has been analysed extensively using a
variety of biochemical and biophysical methods (2,4), is
attributed to the strong hydrogen bonds between the NH/
C=O groups of threonines in ActD and the correspond-
ing N3/N2 sites of adjacent guanine bases of the GpC step
(5). The binding afﬁnity of ActD to GpC sites is also
inﬂuenced by ﬂanking sequences due to their interactions
with the cyclic pentapeptide lactone rings of ActD (5–8).
CGG triplet repeat expansions (TREs) within genes are
associated with various neurological diseases (9,10). The
correlations of these unusual repetitive sequences with the
aetiology of these diseases and the mechanism by which
those repeats are expanded during replication have been
extensively studied. The massive CGG expansion found in
neurodegenerative disorders may be caused by the slipped
register of the DNA complementary strands along with
the transient formation of hairpins during DNA replica-
tion (11,12). During this process, DNA polymerase pauses
with relocation of the primer, which results in the elong-
ation of integral numbers of triplets to produce TREs. The
transient intrastrand hairpin structure containing the mis-
matched base pairs has been proposed to promote DNA
slippage and is a causative factor for DNA expansion
(13–15). For example, the CGG TREs in the coding
sequence of the FMR1 (Fragile mental retardation 1)
gene result in the production of an aberrant protein that
has a critical role in the pathogenesis of these diseases (16).
The binding of ActD to non-canonical sequences has
been previously studied. It has been reported that two
equivalents of ActD bind to the partially overlapping
G–C sites on the G–C–G–C segment, and a bend is
induced by crowding of the neighbouring pentapeptide
(17). In addition, the molecular basis for the tight
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binding of ActD to a -TGCT- sequence has been reported
based on the structure of the ActD–GATGCTTC complex
in which the N-methyl group of N-methylvaline (MeVal)
was shown to ﬁt snugly in a cavity, which is created by the
T:T mismatched base pair, during the TpG step (8). ActD
was also able to bind to certain single-stranded sequences
with a high afﬁnity (18). Interestingly, when (CGG)n
triplet sequences adopt a hairpin arm (as part of a cruci-
form) or duplexes form between antiparallel CGGs, they
contain many GpC ActD-binding sites that alternate with
G:G mismatches. Here, we solved the crystal structure of
the ActD–ATGCGGCAT complex and analysed the
properties of ActD binding to understand the structural
basis of the tight binding of ActD. This complex was
studied because the -GCGGC- region, which is a part of
(CGG)n triplet repeat sequences, creates two GpC sites
separated by a G:G mismatch. We characterized the
stabilizing and structural effects of ActD on CGG triplet
sequences using biophysical analysis. These results
provided valuable information regarding the action of
ActD on the CGG triplet sequence associated with neuro-
logical disease.
MATERIALS AND METHODS
Drug and oligonucleotides
The synthetic DNA oligonucleotides were puriﬁed by gel
electrophoresis. ActD was purchased from Sigma
Chemical Co. (St. Louis, MO, USA). The concentrations
of the ActD solutions were determined based on the
optical density (e224 nm=35 280M
1 cm1). The oligo-
nucleotide ATGCGGCA[br5U] was used for the MAD
experiments. The oligomer extinction coefﬁcients were
calculated according to tabulated values of the monomer
and dimer extinction coefﬁcients, with reasonable assump-
tions. The standard buffer used in the ultraviolet (UV) and
circular dichroism (CD) studies contains 50mM NaCl
buffered with 20mM Tris–HCl buffer at pH 7.3.
Melting temperature measurements
The Tm values of the DNA duplexes were analysed as
previously described using a JASCO UV/VIS spectropho-
tometer by monitoring the sample absorption (O. D.) at
260 nm (19,20). The experiments were performed by
increasing the temperature from 0C to 100C at a rate
of 0.5C/min. The temperature was recorded every 30 s.
The Tm values were determined based on the polynomial
ﬁtting of the observed curves and were considered to be
the temperatures corresponding to the half-dissociation of
the DNA duplexes. The ﬁrst derivative of the absorption
with respect to the temperature (dA/dT) of the melting
curve was computed and used to determine the Tm.
CD spectroscopy
CD spectra were collected between 325 and 200 nm at
1 nm intervals using a JASCO-815 spectropolarimeter.
The temperature was controlled using a circulating water
bath. All of the spectra were calculated as the average of
three runs. The methods used for the CD spectral analyses
have been previously described (21,22).
Surface plasmon resonance–binding analysis
The afﬁnity between the drug and the DNA duplexes was
measured using a BIAcore 3000 A surface plasmon reson-
ance (SPR) instrument (Pharmacia, Uppsala, Sweden)
with a SensorChip SA5 (Pharmacia) by monitoring the
change in the refractive index of the sensor chip surface.
In general, these changes are assumed to be proportional
to the mass of the molecules bound to the chip and are
recorded in resonance units (RU) (23). The 50-biotin-
labelled hairpin DNA duplexes used in the SPR experi-
ments were puriﬁed by polyacrylamide gel electrophoresis.
To control the amount of DNA that bound to the
streptavidin SA chip surface, the biotinylated oligomer
was manually immobilized on the chip surface. ActD
was prepared in a solution of 20mM Tris–HCl buffer
(pH 7.3) and 50mM NaCl. Different concentrations of
the drug were passed over the chip surface for 180 s at a
ﬂow rate of 70 ml min1 to reach equilibrium. One of the
ﬂow cells was used as a blank control. Then, the blank
buffer solution was passed over the chip to initiate the
dissociation reaction, and this ﬂow was continued for an
additional 300 s to complete the reaction. Next, the surface
was recovered by washing with 10 ml of 10mM HCl.
Sensorgrams for the interactions between the hairpin
DNA duplexes and the drugs were analysed using the
BIA evaluation software, version 3. Because 50-AAAGC
TTTTGTAAAGCTTT-30 (GC1) provides one site for
ActD binding, the SPR-binding constants of ActD
bound to GC1 were calculated using a 1:1 Langmuir
binding model as described below:
A+B >
ka1
kd1
AB
In addition, 50-ATGCGCATTGTATGCGCAT-30
(GC2), 50-ATGCGGCATTGTATGCGGCAT-30 (GG2)
and 50-ATGCATGCATTGTATGCATGCAT-30 (AT2)
provided two sites for ActD binding. The SPR-binding
Figure 1. Chemical structure of ActD. The cyclic pentapeptides
attached to the quinonoid and benzenoid rings of the phenoxazone
group are labelled a and b, respectively.
Nucleic Acids Research, 2013, Vol. 41, No. 7 4285
 at N
ational Chung H
sing U
niversity Library on February 19, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
constants of ActD bound to GC2, GG2 and AT2 were
calculated using bivalent ligand model, which describes
the two sequential binding events for ActD binding to
DNA duplex as described below:
A+B >
ka1
kd1
AB >
ka2
kd2
AB2
This model usually takes cooperative effects into
account. The ﬁt was considered acceptable when the
chi-square values were <3.
Crystallography
Crystals were obtained from solutions containing 1.0mM
single-stranded DNA, 1.5mM ActD, 40mM sodium-
cacodylate buffer (pH 6.0), 3mM MgCl2, 5mM CaCl2,
10mM spermine and 8% 2-Methyl-2,4-pentanediol
(MPD) solution. The solutions were previously
equilibrated at 4C with 500 ml of 50% MPD using the
vapour diffusion method (24). The crystallographic
statistics are listed in Supplementary Table S1. The
DNA in the complex is numbered A1 to T9 in one
strand and A10 to T18 in the complementary strand.
The two ActD molecules are numbered ActD1 and
ActD2. Diffraction data for the ActD–ATGCGGCA
[br5U] complex crystal were measured at 100K at the
National Synchrotron Radiation Research Center 13B1
beamline using an ADSC Q315r detector. The
crystallographic data integration and reduction was
performed using the software package HKL2000 (25).
The MAD data were collected at four wavelengths using
bromine as the anomalous scattering atoms. The phases
were calculated as implemented in the crystallographic
suite Crystallography & NMR System (CNS) (26). The
ﬁgure-of-merit values were 0.50 and 0.74 before and
after density modiﬁcation, respectively. The resulting
MAD electron density map at 2.8 A˚ resolution was used
to build the initial models using the program Miﬁt (http://
code.google.com/p/miﬁt/). The structure was reﬁned using
the simulated annealing procedure incorporated in CNS
(26). The DNA force ﬁeld parameters reported by
Parkinson et al. (27) were used. The force ﬁeld for ActD
was generated using the atomic coordinates of its high-
resolution crystal structure. The torsion angles were
calculated using the CURVES v5.3 program (28).
RESULTS
Overall crystal structure of the ActD–DNA complex
To understand the structural basis of (CGG)n triplet
repeat binding by ActD, we solved the crystal structure
of ActD bound to ATGCGGCAT at 2.8 A˚ resolution
using the multiple wavelength anomalous diffraction
method with 5-bromo-U-DNA. The DNA is embedded
with the (CGG)n triplet sequence signature. The ﬁnal
reﬁned electron density map at 2.6 A˚ resolution was of
good quality. Supplementary Figure S1 shows an
electron density map indicating the phenoxazone plus
the cyclic pentapeptide ring in the minor groove of DNA.
The asymmetric unit of the unit cell contains only one
duplex complex consisting of the nonamer palindromic
DNA sequence, d(ATGCGGCAT)2, bound by two
ActD drug molecules (labelled ActD1 and ActD2)
(Figure 2A and B). A symmetrical duplex containing a
2-fold axis running though the centre of the duplex was
observed in our structural analysis. The structure revealed
many unexpected features. In the complex, two ActD
molecules were observed to bind at adjacent overlapping
GpC sites, and two guanines are looped out and
perpendicular to the long axis of the ﬂanking G:C base
pairs (Figure 2A). The general mode of ActD binding to
each of the GpC sites resembles that of previously
reported crystal structures of ActD–DNA complexes (2).
Previous crystallographic analyses showed that CGG/
CGG contain C:G and G:C Watson–Crick base pairs
with a central non-canonical G:G pair in which one
guanosine is always in the syn conformation, whereas
the other is in the anti conformation (29). In this study,
on ActD binding, we found that the 30 guanosine in the
central CGG triplet is ﬂipped out of the duplex DNA and
A
A1
T18
A10 T9
A1
T18
A10 T9
α
β
α
β
ActD1
ActD2
ActD1
ActD2
α
β
α
β
B
C16
C13
C4
C7
G3
G12 G6
G5
G14
G15
Figure 2. (A) Stereoscopic drawings of the crystal structure of the 2:1
ActD–(ATGCGGCAT)2 complex (ActD is shown as a van der Waals
drawing, and DNA is shown using a skeletal line drawing). Two ActD
molecules, ActD1 (yellow) and ActD2 (green), which are related by a
2-fold symmetry operation, bind to DNA by intercalating its
phenoxazone ring at the two GpC steps with cyclic pentapeptide
moieties located in the minor groove, and two guanines (G6 and
G15) are looped out and perpendicular to the long axis of the
ﬂanking G:C base pairs. (B) Stereoscopic drawings of the
ActD–DNA complex (ActD molecules are shown as balls and sticks,
and DNA in shown as a skeletal line drawing) viewed from the minor
groove direction.
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the 50 cytosine that was originally paired with it forms a
base pair with the guanosine from the destructed G:G
mispair in d(ATGCGGCAT). The phenoxazone rings of
ActD1 (yellow) and ActD2 (green) intercalates into the
G3-C16/C4-G14 and G5-C13/C7-G12 base pairs,
respectively, from the minor groove side. The G6 and
G15 positions, which are no longer base paired within
the duplex, are ﬂipped out and are perpendicular to the
long axis of the ﬂanking Watson–Crick base pairs
(Figure 2B).
The cyclic pentapeptide lactone rings of individual
ActD molecules project in the same direction as the
intercalated phenoxazone ring in the ActD–d(ATGCGG
CAT) complex (Supplementary Figure S2). The proximity
of the two ActD molecules in the minor groove results in
contacts between the b and a peptide rings. The bulky
MeVal side chain from the a ring of ActD2 is in van der
Waals contact with the cyclic side chain of the Pro of the b
ring of ActD1. Similarly, crowding occurs between MeVal
of the b ring of ActD1 and the cyclic side chain of the Pro
of the a ring of ActD2 and between the N-methyl group of
the Sar of the a ring of ActD2 and the N-methyl group of
the Sar of the b ring of ActD1. Such extensive
hydrophobic interactions provide stabilization forces
between the two ActD molecules. The contacts between
the b and a peptide rings result in a sharp bend of the
nonamer DNA duplex in which the two halves are tilting
towards the direction of the major groove (Figure 2A).
The helix axis of the top half (with an A1-T18 terminal
base pair) is bent with an angle of 87.8 away from that
of the bottom half (with an A10-T9 terminal base pair)
according to the CURVE results. The bending angle is far
greater than those observed in the current structure of the
DNA–drug complex. To relieve the steric conﬂict between
the inwardly pointing bulky peptide rings associated with
the two ActD molecules bound at partially overlapping
sites on the duplex, the two bulky peptide rings expand
the minor groove width at the central (C4-G14)·(G5-C13)
step in the ActD–d(ATGCGGCAT) complex and force
the two backbones to unwind to generate additional
space (Figure 2B).
Structure of the binding site
Figure 3 shows a close-up view of the ActD–DNA
complex at the ActD-intercalation site. The two halves
of the complex show global similarities as well as local
differences with an r.m.s.d. between the two halves
(DNA+ActD) of 1.33 A˚ (Figure 3A and B). In the
complex, ActD1 and ActD2 maintain a pseudo 2-fold
symmetry. However, there is a rotation (180) between
ActD1 and ActD2. The phenoxazone ring of ActD1 (and
ActD2) is intercalated at the G3-C16/C4-G14 base pairs
(and G5-C13/C7-G12 base pairs) from the minor groove
side by pushing out G6 (and G15) (Figure 3A and B). The
strong G–C preference of ActD binding can even extrude
nucleotides located between a 50-G and a 30-C (5,30).
There are extensive stacking interactions between the
phenoxazone ring and the guanine bases from both sides
of the ring, which were also observed in the X-ray
(2,31) and nuclear magnetic resonance (NMR) structures
(8,32). The ﬂipped-out G6 and G15 sites, which are not
disordered, form a perpendicular p-ring/C-H interaction
with the chromophore groups 4-CH3 and 6-CH3 in
ActD2 and ActD1, respectively (Figure 3C). One
hydrogen bond was detected for G14 and G15. In
addition, the ﬂipped-out G6 and G15 also form
hydrogen bonds and mutual stacking interaction with
the ﬂipped out G6 and G15 of other symmetry-equivalent
duplexes (Supplementary Figure S3). In the ActD1–DNA
complex, G3 and C16 maintain a standard Watson–Crick
base pair (Figure 3C). However, G14 has adopted a syn
conformation that may maximize the stacking interaction
between the purine and the phenoxazone ring leading to
the formation of Hoogesteen-type base pairing with C4.
Strong intermolecular hydrogen bonds form between G3-
N3 and the NH of Thr(a) of ActD1 and G3-N2 and the O0
of the phenoxazone ring of ActD1 (Supplementary Figure
S4A and B). In the ActD2–DNA complex, G12 and C7
also maintain standard Watson–Crick base pairing. The
G5-C13 base pair has Watson–Crick geometry with two
full hydrogen bonds (Figure 3C). Strong intermolecular
hydrogen bonds are formed between G12-N2 and the
CO of ActD2 Thr(b) and G5-N2/N3 and the CO/NH of
ActD2 Thr(a) (Supplementary Figure S4A and C). In
addition to these hydrogen bonds, one bridging water
molecule also plays an important role in mediating the
interactions between ActD2 and the DNA duplex
(Supplementary Figure S4B).
The outward outer edges of the peptide rings (i.e. the
Sar-MeVal dipeptide part) from ActD reach beyond the
ﬂanking A:T base pairs in the minor groove. The N-
methyl group of the MeVal from the ActD2 b and
ActD1 a rings are wedged between the T11pG12 and
T2pG3 steps, respectively (Figure 3D). In addition, the
methyl group of the MeVal from the ActD1 b and
ActD2 a ring from the inwardly outer edges of the
peptide rings is wedged between the C13pG14 and
C4pG5 steps, respectively, which causes unwinding in
this step (Figure 3E). ActD2 has a similar overall
conformation as that of free ActD (r.m.s.d.=0.81)
(Supplementary Figure S5) even though ActD1 has a
different conformation compared with free ActD
(r.m.s.d.=1.52), especially at the proline residue (33).
The proline side in the b and a peptide rings of ActD2
pushes the cytosine of the C7:G12 and G5:C13 base pairs
towards the major groove side, which reduces the base
stacking on the DNA strand closest to the proline
(Figure 3D and E). However, the proline side of the
peptide ring of ActD1 moves away from the DNA surface.
DNA backbone torsion angles and helical parameters
of the DNA duplex
The entire DNA structure is distorted by the binding of
two ActD molecules. The binding of ActD to the central -
GCGGC- causes considerable changes in the DNA
backbone torsion angles and helical parameters relative
to those of B-DNA (Supplementary Tables S2 and S3).
The glycosidic torsion angles, , of most of the residues
fall into an anti conformation (160 to 300) with the
exception of G14, which adopts a syn conformation
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Figure 3. Enlarged side view of the ActD–ATGCG region (ActD is shown as a ball-and-stick model, and DNA is shown as a skeletal model). The
two phenoxazone rings of ActD1 (left) and ActD2 (right) are individually intercalated into the G3pC4 step in A and the G12pC13 step in B,
respectively C–E. The detailed conformation showing the stacking interactions in the ActD–DNA complex at various base pair steps of the reﬁned
structure. Hydrogen bonds are shown as blue dotted lines. Water is shown as a blue sphere.
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(=108). The majority of sugar puckers preserve C20-
endo or closely related C30-exo structures, suggesting
alternating C20-endo/C30-endo conformations, which is
a conﬁguration frequently found in intercalator-
dinucleotide monophosphate complexes, are not required
for ActD intercalation (34). In addition, ﬂipped-out G6
and G15 are most evident at torsion angles (x) of 102.4
and 78.6, which differ by 289 and 265, respectively,
from those observed in A-DNA and B-DNA. C4 and
G14, which adopt syn (G14) and anti (C4) conformations,
form Hoogesteen base pairs that exhibit a higher propeller
twist angle and stretch distance than other G:C base pairs.
An increase of 6.7 and 8.2 A˚ for the two GpC steps at
the intercalation sites in the ActD–DNA complex was
observed and is similar to changes observed in the
structures of DNA oligomers on DNA intercalator
binding (34–36). The DNA helical twist at the ActD1
intercalation site at the GpC step is 62.5 indicates that
this step is overwound (Supplementary Figure S6A).
However, the helix unwinds by 30 at the ActD2
intercalation site at the G–C step (twist angle 5.8).
Interestingly, the duplex is unwound at the central CpG
step to generate a left-handed helix with a twist angle of
43.45, which is characteristic of the Z-DNA structure.
We propose that this action may relieve the steric conﬂict
between the inwardly pointing bulky peptide rings
associated with the two ActD molecules and absorbs the
torsional stress caused by over-winding at the GpC step
on ActD1 binding. In addition, there is a signiﬁcant
increase in the width of the minor groove in the DNA–
ActD complex in the 17–18 A˚ range relative to the minor
groove widths of 6 and 11 A˚ in B-DNA and A-DNA,
respectively. Large positive roll and tilt angles were also
detected in the three central steps of d(ATGCGGCAT) on
ActD binding, which results in a sharp bending of the
DNA helix towards the major groove (Supplementary
Figure S6B and C). Another distortion induced by the
ActD is a slide displacement in the ﬁve central steps of
d(ATGCGGCAT). These DNA conformational changes
result in an opening and widening of the minor groove to
accommodate two intercalated ActD molecules bound at
partially overlapping sites on the DNA.
Crystal packing of ActD–DNA complexes
There are two different major packing interactions that
occur between the two asymmetric units in the crystal
lattice (P6522) (Supplementary Figure S7A), i.e. end-to-
end and end-to-side, that are mediated by p–p stacking
and van der Waals contact, respectively (Supplementary
Figure S7B). At one interface of the end-to-end packing,
the end of one DNA duplex molecule is packed against the
end of another molecule with a base-stacking distance of
3.4 A˚ between the contacting terminal residues of the
ActD–DNA complex (A1-T18) of the independent
asymmetric units. The other interface in the end-to-side
packing is stabilized by the formation of intramolecular
van der Waals contact between the terminal residues of the
ActD–DNA complex (A8-T9) of the independent
asymmetric units.
UV melting, CD and SPR analysis of ActD bound to
DNA duplexes
We characterized the stabilizing and structural effects of
ActD on d(ATGCGGCAT) (GG2) by UV melting, CD
and SPR analysis. For comparison, the DNA duplexes,
GC2 and AT2, which contain two related GpC sites that
are either adjacent or non-overlapping, respectively, and
GC1, which contains one central GC step site, were used
as the reference sequences in this study. These duplexes
were expected to be intercalated at the central GpC
location by an ActD molecule (Figure 4A). The melting
temperatures of the DNA duplexes with or without ActD
were determined by recording their A260 values at different
temperatures (Table 1). In the absence of ActD, GG2 with
a central G:G mispair showed a lower Tm value than GC2
and AT2. In a concentration-dependent manner, ActD
can stimulate the stability of DNA duplexes. However,
the Tm values of GG2 and AT2 are more than those
of GC1 and GC1 after the addition of ActD at various
drug/DNA ratios (Figure 4B). These data suggest that
ActD can show a high preference for stabilizing two GC
sites ﬂanking a non-canonical G:G pair or two standard
AT base pairs. The Tm values of the GC2 and GG2
duplexes with ActD are lower than that of AT2 due to
crowding between two neighbouring cyclic peptides of
ActD at two overlapping GpC sites, which results in a
severe bending of the helix.
Figure 4C shows the CD spectra of the DNA duplexes
including GC1, GC2, GG2 and AT2 with and without
ActD. The CD spectra of the DNA duplexes showed the
same proﬁles (i.e. a band of negative and positive peaks at
250 and 275 nm that are typical of B-DNA). After binding
to ActD, GC1, GC2, GG2 and AT2 showed an increase in
the intensity of their CD spectra at 250 nm and a red
shift from 275 to 290 nm, which revealed a conformational
change in the DNA on ActD binding. It is interesting to
note that GG2 exhibited the largest change in its CD
intensity at 290 nm in the presence of ActD indicating
the largest conformational change of GG2 on ActD
binding compared with other DNA duplexes.
To characterize the binding afﬁnity of ActD for GG2,
ActD was allowed to interact with biotin-labelled hairpin
DNA duplexes at various concentrations, and the results
were monitored by SPR (Supplementary Figure S8). The
tested DNA formed self-complementary hairpin duplexes
using 50-TGT-30 trinucleotides as a loop region. In
Figure 4D, the association between the hairpin DNA
duplexes and ActD is shown by an increase in the RU
values, whereas the dissociation of these two species is
indicated by a decrease in the same trace. According to
the SPR sensorgram, the interactions between GG2 and
ActD exhibited the highest DNA-binding capacity (202
RU) compared with those between other DNA duplexes
and ActD.
Kinetic experiments were performed by measuring the
parameters of the binding between ActD and its target
DNA duplexes (Table 2). The kinetic constants of
association (ka in M
1s1) and dissociation (kd in s
1)
for ActD binding were measured based on the calculations
from the association and dissociation phases of the SPR
Nucleic Acids Research, 2013, Vol. 41, No. 7 4289
 at N
ational Chung H
sing U
niversity Library on February 19, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
traces, respectively. Because GC1 provided one site for
ActD binding, only one ka1 and kd1 values that contribute
towards the respective association constants (Ka1) were
observed in the ActD–GC1 complex. In addition, GC2,
GG2 and AT2 provide two sites for ActD binding. The
ka1, kd1 and ka2, kd2 values contribute towards the
respective association constants (Ka1 and Ka2) for the
two binding modes obtained for the ActD–GC2, ActD–
GG2 and ActD–AT2 interactions. GG2 was shown to
have a higher ka1 and ka2 compared with other duplexes
containing regions with two related GpC sites. For the
dissociation rate constants, GG2 had a higher dissociation
rate constant (kd1=5.71 103 s1) relative to GC2 and
AT2 (kd=1.15 103 and 0.46 103 s1, respectively).
The kd2 values of GC2, GG2 and AT2 were essentially the
same. The association constants (Ka) were calculated as
ka/kd (M
1) and listed in Table 2. AT2 showed the
highest Ka1 value, which is 2-fold and 4-fold larger
than the Ka1 of GC2 and GG2, respectively, whereas
GC1 exhibited the lowest Ka1 among all of the duplexes.
The Ka2 (1.55 106) of GG2 was slightly higher than the
Ka2 values of AT2 and GC2. In addition, GG2 had a
higher Ka1 value that was 2-fold greater than the Ka2
of GG2, suggesting that the binding of two ActDs to
GG2 may exhibit negative cooperative binding.
Binding of ActD to CGG repeats
The oligo (CGG)16 was used to further characterize the
action of ActD on the CGG repeats. This sequence forms
intrastrand hairpins consisting of mismatched base pairs
that promote primer–template slippage during DNA
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Figure 4. (A) The DNA duplexes including GC1, GC2, AT2 and GG2 were used in this study (squares represents the binding sites for the
phenoxazone ring of ActD). (B) The effect of ActD at various concentrations on the "Tm values of GC1, GC2, GG2 and AT2 (3 mM) in
standard buffer. (C) The CD spectra of GC1, GC2, AT2 and GG2 (4 mM) in standard buffer alone and with 10 mM ActD are shown. The CD
spectra of ActD–DNA complexes were obtained by subtracting out the spectra of ActD. (D) A sensorgram of the ActD–DNA interaction between
immobilized hairpin DNA and the target ActD obtained by subtracting the reference control is shown. The concentration of the drug was 2 mM in
50mM NaCl buffered with 20mM Tris–HCl buffer at pH 7.3.
Table 1. The effects of ActD at various concentrations on the
melting temperature of various DNA duplexes at 3 mM
DNA forms 0 mM
ActD
3 mM
ActD
6mM
ActD
12 mM
ActD
GC1 28.1 34.2 40.2 43.3
GC2 36.9 52.5 57.6 61.3
GG2 28.8 46.3 54.6 60.1
AT2 37.4 59.2 67.6 70.2
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replication. The structure of (CGG)16 offers many GC
sites ﬂanking a G:G mispair for ActD binding. To
explore the ActD interactions and any subsequent
structural perturbations to the (CGG)16, CD spectra
were monitored in the presence of various concentrations
of ActD. Figure 5A shows the CD spectra (320–200 nm) of
(CGG)16 on addition of ActD. The CD spectra of
(CGG)16 alone showed a band with a negative peak at
260 nm and two small shoulders appearing at 276 and
240 nm, which is a pattern that is typical of undeﬁned
structures. After binding of ActD, (CGG)16 exhibited a
concomitant increase in a positive peak at 295 nm and
two negative peaks at 205 and 246 nm. These results
suggest that long CGG repeats also show substantial
DNA conformational change on addition of ActD. The
occurrence of one isobestic point at 270 nm, which
remains largely unchanged, demonstrates the presence of
one-mode conformation alternation of DNA by binding
to ActD.
To determine the stoichiometry between ActD and
(CGG)16, the CD intensity of DNA at 295 nm with
increasing concentrations of ActD was performed at
25C. A plot of the CD intensity of the signal at 275 nm
as a function of the concentration of added ActD showed
that a plateau was reached when six equivalents of ActD
had been added. The points of intersection of two
extrapolated lines (initial and ﬁnal), which represent the
saturation levels, indicate a 6:1 stoichiometry between
ActD and DNA (Figure 5B).
To determine the stabilizing effects of ActD on the
thermodynamics of the (CGG)16 hairpin formation, the
melting temperatures of the DNA duplexes in the
presence of ActD at various concentrations were
determined following their complex formation by
recording the A260 values at different temperatures
(Table 3). Several DNA intercalators, including ethidium
bromide, daunorubicin and ellipticine, were used as
reference compounds. Daunorubicin and ellipticine are
GC-speciﬁc intercalators. Daunorubicin at 2, 4, 6, 8 and
12 mM elevated the Tm value of (CGG)16 by 1.3C, 3.7C,
6.2C, 8C and 10.1C, respectively (Figure 5C). The Tm
value of (CGG)16 was estimated to increase by 3.7
C,
5.2C, 7.2C, 10.1C and 11.8C on treatment with 2, 4,
6, 8 and 12 mM ellipticine, respectively. Ethidium bromide
at various concentrations was unable to stabilize the
hairpin structure of (CGG)16. The addition of ActD to
(CGG)16 at 2, 4, 6, 8 and 12 mM resulted in a dramatic
increase in the Tm value to 10.8
C, 16.6C, 19.4C, 21.7C
and 23.4C, respectively, demonstrating that ActD
exhibits higher DNA-stabilizing effects towards (CGG)16
than do the other compounds.
DISCUSSION
Small-molecule ligands that bind to CXG repeats could
provide potent biological applications. For example, a
naphthyridine–azaquinolone conjugate and a
naphthyridine carbamate dimer that target (CAG)n and
(CGG)n, respectively, and bind to A:A and G:G
mismatches, respectively, were developed to probe the
length of a repeat (37–39). Previous studies reported that
DNA-acting drugs, such as mitomycin C, doxorubicin and
chromomycin A3, can prevent the expansion of the CXG
triplet repeats (40,41). The (CXG)n triplet repeat sequence
has extensive GpC sequence clustering, which provides a
potent ActD-binding target. Our current studies
demonstrate that ActD can tightly bind to consecutive
GpC sites that are separated by a G:G mismatch.
Certain signiﬁcant conformational distortions including
a particular nucleotide loop-out, a sharp bend of the
helix and an unwinding to generate a left-handed DNA
twist were observed. The NMR structure of the ActD
bound to a 50-GGC/CCG-50 site was also reported to
contain looped-out nucleotides in the DNA strand with
one of the looped-out bases perpendicular to the ActD
chromophore (30). A similar conformational feature
(nucleotide loop-out) was observed in the complex of
trioxacarcin bound to a DNA duplex (42). In addition,
the looped-out bases play an important role in certain
DNA–protein interactions (43). For example, the DNA
repair enzyme (i.e. DNA glycosylase) ﬂips the damaged
base out of the double helix into an active site pocket to
excise it.
There are parallels in the observed mode of DNA-
binding in the current study of the ActD–d(ATGCGGC
AT) complex and an NMR study from Patel’s group on
the ActD–d(AAGCGCTT) complex (two drugs per
duplex) (17). For both complexes, two ActD molecules
bind at adjacent overlapping GpC sites. The contacts
between the peptide rings of two different ActD molecules
result in a bend of the DNA duplex and an unwinding at
the central GC step in structures as well as a widening and
opening up of the minor groove accompanied by tilting
towards the major groove. Of particular interest is the
bend angle (88) in the ActD–d(ATGCGGCAT)
complex, which is greater than the bend angle of 20
derived from the NMR solution structure. The sharp
bend associated with minor groove complex formation
has been independently observed in the structures of the
complexes formed between the tetraazaphenanthrene
ligand and chromomycin A3 and their DNA target sites
(44,45). Both interactions are accompanied by a widening
of the minor groove and unwinding of the helix. In
Table 2. Binding parameters for ActD and hairpin DNA duplexes determined by SPR
DNA forms ka1 (M
1S1) ka2 (M
1S1) kd1 (S
1) kd2 (S
1) Ka1 (M
1) Ka2 (M
1)
GC1 3.51 103 1.53 103 2.29 106
GC2 6.98 103 0.94 103 1.15 103 0.94 103 6.07 106 1.01 106
GG2 1.76 104 1.70 103 5.71 103 1.14 103 3.08 106 1.55 106
AT2 5.86 103 1.02 103 0.46 103 0.98 103 12.87 106 1.04 106
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addition, the left-handed helix at the central GpC step of
d(ATGCGGCAT) was induced by ActD binding, which
has not been previously reported in other DNA–drug
complex structures.
Previous studies have shown that the GpC site is the
preferred intercalation site for ActD where A or T
residues adjacent to the intercalation site are favoured
(2). In agreement with the Tm results that showed ActD
formed a more stable complex with AT2 than the other
duplexes, our SPR results clearly showed that the binding
afﬁnity of the ﬁrst ActD to the DNA duplexes follows the
following order: AT2>GC2>GG2>GC1. However,
ActD was shown to bind to GG2 quickly. The CGG
repeat helices exhibited a smooth bend caused by
preferential stacking interactions at the guanine bases.
The bend is produced by a roll in the base pairs along
their long axes in the direction that compresses the wide
major groove of the double helix. Therefore, it is likely
that this major-groove compression and the concomitant
widening of the minor groove partially contribute to the
fast binding of the ActD to the CGG triplet repeats. In
addition, the rates of dissociation of the ﬁrst ActD (ka1)
from the DNA duplexes with two related GC sites were
signiﬁcantly modulated by the inserted base pairs ﬂanked
by the two GC sites. For example, the ﬁrst ActD
dissociates from GG2 faster compared with AT2 and
GC2. According to the crystal structure of the ActD–
d(ATGCGGCAT) complex, the severe bending of the
helix is most likely responsible for this observation. Our
biophysical studies showed that the binding of ActD to
d(ATGCGGCAT) occurs via a pairwise binding model.
The SPR results indicating that the binding constant for
one of the binding sites is 2-fold greater than the value for
the other site, which can be explained by the structural
differences between the two binding sites as previously
described. For example, the GpC step for the ActD2
binding is tightly wound such that the minor groove
becomes deeper and the proline residue of ActD2 ﬁts
into a hydrophobic pocket in this groove. In contrast,
the GpC step for ActD1 binding is unwound such that
the minor groove becomes shallow and wide and the
proline residue of ActD1 remains distant from the DNA
surface without a signiﬁcant interaction. In addition, there
are more hydrogen bonds in the DNA–ActD2 complex
than in the DNA–ActD1 complex.
In the (CGG)16 triplet repeats, there is an extensive
clustering of GpC sequences separated by a mismatched
G:G base pair. This clustering provides an excellent ActD-
binding target. Although (CGG)16 contains seven GC
sites, ActD binds to (CGG)16 with a 6:1 drug/strand
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Figure 5. (A) CD spectra of (CGG)16 (1 mM) with ActD at various
concentrations. The CD spectra of ActD–DNA complex were
obtained by subtracting out the spectra of ActD. (B) CD titration
of (CGG)16 against ActD with varied CD intensities at 295 nm as a
function of the molar equivalents of ActD–DNA at 25C. A DNA
concentration of 1 mM, which was buffered by 20mM sodium-
cacodylate buffer at pH 7.3, was used. The two solid lines represent
the initial binding curve of ActD to DNA and the curve that
reaches the plateau. (C) Tm values of (CGG)16 (1mM) in standard
buffer induced by various DNA intercalators at different drug/DNA
ratio.
Table 3. The effects of drugs at various concentrations on the
melting temperature (C) of (CGG)16 at 1 mM
Drugs 0 mM 2 mM 4 mM 6 mM 8 mM 12 mM
EtBr 70.6 70.1 69.9 70.4 69.8 70.2
Ellipticine 70.6 73.3 75.8 77.8 80.7 82.4
Daunorubicin 70.6 71.9 74.3 76.8 78.6 80.7
ActD 70.6 81.4 87.2 90.0 92.3 94.0
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binding stoichiometry supporting the concept that binding
to the (CGG)n repeat proceeds in a pairwise combination
(Supplementary Figure S9), which has been demonstrated
for the ActD–d(ATGCGGCAT) complex. We also
provided evidence that ActD can modulate the stability
and conformation of an intrastranded hairpin structure
in CGG-repeat sequences. Currently, no treatments exist
for neurological diseases associated with DNA TRE. The
length of the repeat is the most important determinant of
these neurological diseases. Chemicals or drugs that
reduce the repeat length may be used to delay onset and
reduce the severity of diseases linked to DNA TRE. Our
results provide a possible biological consequence of ActD
binding to CGG triplet repeat sequences associated with
neurological disease.
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